GPC/SEC, often coupled with RI, Viscometry and/or LS detection, is the method of choice to characterize polymers and proteins.
GPC/SEC, often coupled with RI, Viscometry and/or LS detection, is the method of choice to characterize polymers and proteins.
The increasing need for precise, reliable and fast results, combined with the requirements for environmentally-friendly instrumentation, is a challenge to both researchers performing GPC analysis and GPC instrumentation manufacturers alike. In addition to these challenges, decreasing solvent-related costs is always a concern for any laboratory.
To address these issues, Tosoh Bioscience and PSS have combined forces to create new and powerful solutions for GPC analysis.
European customers are invited to a one day Road Show event in 8 different European cities.
http://www.polymer.de/fileadmin/custom_documents/RoadShowInviation2010.pdf
Key Learning Objectives:
The webcast will take place on April 14, 2010 at 3:00 PM CEST
Speakers:
Tatsuji Kushimoto
Executive Vice President
Tosoh Bioscience LLC & GmbH
Dr. Daniela Held
Customer Support and Training
PSS Polymer Standards Service GmbH
LC–MS/MS Quantification of Plasma Proteins in Elephant Seals to Advance Wildlife Conservation
November 12th 2024Liquid chromatography and tandem mass spectrometry (LC–MS/MS) was used to show that repeated stress can cause delayed but sustained changes in blood plasma proteins associated with water conservation, immune responses, fat metabolism, insulin sensitivity, iron recycling, and hormone transport in elephant seals. Some of these changes may be novel markers of recent and chronic stress exposure in marine mammals.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.